In this episode, host Alyssa Watson, DVM, talks with Diane Delmain, DVM, DABVP, about her recent Clinician’s Brief article, “Remdesivir & GS-441524 for Treatment of FIP.” Dr. Delmain discusses the relationship between the two drugs, the hurdles veterinarians face in prescribing them, and the FDA’s stance on compounded GS-441524. She also covers the limitations of retrospective data and the risks associated with unregulated products. Plus, Dr. Delmain shares advice for monitoring for adverse effects and long-term care for cats recovering from FIP.
Resources:
Contact:
Where To Find Us:
The Team: